Last reviewed · How we verify
Endometrial carcinoma
Approved treatments
- Depo-Provera · Pfizer
Depo-Provera works by binding to the progesterone receptor in the body, which helps to regulate the menstrual cycle and prevent pregnancy. - Endometrin · Ferring
- Megace · Bristol-Myers Squibb
- Progesteron · Minia University
- megestrol · National Center for Research Resources (NCRR)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Endometrial carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Endometrial carcinoma treatment landscape brief
- Endometrial carcinoma treatment updates RSS
Frequently asked questions about Endometrial carcinoma
What drugs treat Endometrial carcinoma?
Tracked treatments include Depo-Provera, Endometrin, Megace, Progesteron, megestrol.
What is the treatment for Endometrial carcinoma?
Standard treatment for Endometrial carcinoma includes Depo-Provera, Endometrin, Megace, Progesteron, megestrol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Endometrial carcinoma patent cliff · Endometrial carcinoma CI report
- Treatment: Depo-Provera · Pfizer
- Treatment: Endometrin · Ferring
- Treatment: Megace · Bristol-Myers Squibb
- Treatment: Progesteron · Minia University
- Treatment: megestrol · National Center for Research Resources (NCRR)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing